Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Frias

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Practice|November 18, 2006
Pramlintide in the treatment of diabetesS V Edelman, T Darsow, J P Frias
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Histoplasma panniculitis in dermatomyositisJ W Huston, P C McNabb, J P Frias
Diabetes & Metabolism|May 11, 2000
Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretionJ P Frias, L Basabe, G Macaraeg, et al.
Diabetes Care|June 17, 2000
Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjectsJ P Frias, J G Yu, Y T Kruszynska, et al.
Diabetes|May 26, 2001
Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in womenJ P Frias, G B Macaraeg, J Ofrecio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 2019
Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trialsJ A Davidson, C Desouza, V Fonseca, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Practice|November 18, 2006
Pramlintide in the treatment of diabetesS V Edelman, T Darsow, J P Frias
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Histoplasma panniculitis in dermatomyositisJ W Huston, P C McNabb, J P Frias
Diabetes & Metabolism|May 11, 2000
Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretionJ P Frias, L Basabe, G Macaraeg, et al.
Diabetes Care|June 17, 2000
Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjectsJ P Frias, J G Yu, Y T Kruszynska, et al.
Diabetes|May 26, 2001
Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in womenJ P Frias, G B Macaraeg, J Ofrecio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 2019
Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trialsJ A Davidson, C Desouza, V Fonseca, et al.
Pageof 1